Currently, the NeuroHub is acquiring, expanding, banking, and distributing iPSCs for the ARCND community. Future goals include optimizing new protocols for making different types of brain cells that are relevant to disease. For example, we now can make different types of neurons and astrocytes in a dish from iPSCs. However, protocols are needed for generating two cell types very important for disease progression in MS – oligodendrocytes and T-cells. Gaining the ability to make these types of cells would improve our overall models of “brains in a dish” and would greatly help our colleagues studying MS here in our center (and beyond!).